Cellectis S.A. Share Price Other OTC
Equities
CMVLF
FR0010425595
Biotechnology & Medical Research
Sales 2024 * | 1.62Cr 1.75Cr 146.37Cr | Sales 2025 * | 7.06Cr 7.65Cr 638.02Cr | Capitalization | 24Cr 27Cr 2.21TCr |
---|---|---|---|---|---|
Net income 2024 * | -7.4Cr -8.02Cr -668.99Cr | Net income 2025 * | -7.1Cr -7.7Cr -641.87Cr | EV / Sales 2024 * | 15.1 x |
Net cash position 2024 * | 6L 6L 5.18Cr | Net cash position 2025 * | 18Cr 19Cr 1.63TCr | EV / Sales 2025 * | 0.92 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 100% |
Latest transcript on Cellectis S.A.
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 20/99/20 |
André Choulika
FOU | Founder | 59 | 20/99/20 |
Arthur Stril
DFI | Director of Finance/CFO | 35 | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 05/20/05 | |
André Choulika
FOU | Founder | 59 | 20/99/20 |
David Sourdive
FOU | Founder | 57 | 20/99/20 |
1st Jan change | Capi. | |
---|---|---|
+54.05% | 5.87TCr | |
-2.02% | 4.13TCr | |
+37.57% | 3.92TCr | |
-10.22% | 2.74TCr | |
+13.42% | 2.65TCr | |
-21.60% | 1.9TCr | |
+2.89% | 1.25TCr | |
+22.40% | 1.19TCr | |
+27.49% | 1.21TCr |